Dr. Jaume conducts basic science/translational research at the University of Wisconsin-Madison. His research program investigates the development, progression and treatment of autoimmune endocrine diseases like diabetes and thyroid diseases, as well as tumor immunity in thyroid cancer.
Juan Carlos Jaume, MD
600 Highland Avenue
Madison, WI 53792
MD, National University of Buenos Aires, Argentina
Endocrine autoimmunity; type 1 diabetes; thyroid diseases
Todorova-Koteva K, Wood K, Imam S, Jaume JC. Screening for parathyroid hormone resistance in patients with non-phenotypically evident pseudohypoparathyroidism. Endocr Pract. 2012 Jul 11;:1-21.
Elagin RB, Jaume JC. Glucose intolerance and diabetes following antigen-specific insulitis in diabetes-susceptible "humanized" transgenic mice. Biochem Biophys Res Commun. 2010 Apr 23;395(1):99-103.
Staii A, Mirocha S, Todorova-Koteva K, Glinberg S, Jaume JC. Hashimoto thyroiditis is more frequent than expected when diagnosed by cytology which uncovers a pre-clinical state. Thyroid Res. 2010 Dec 20;3(1):11.
Elagin RB, Balijepalli S, Diacovo MJ, Baekkeskov S, Jaume JC. Homing of GAD65 specific autoimmunity and development of insulitis requires expression of both DQ8 and human GAD65 in transgenic mice. J Autoimmun. 2009 Mar 14. [Epub ahead of print]
Haymart MR, Repplinger DJ, Leverson GE, Elson DF, Sippel RS, Jaume JC, Chen H. Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage. J Clin Endocrinol Metab. 2008 Mar;93(3):809-14. Epub 2007 Dec 26.
Mirocha S, Elagin RB, Salamat S, Jaume JC. T regulatory cells distinguish two types of primary hypophysitis. Clin Exp Immunol. 2009 Mar;155(3):403-11. Epub 2008 Dec 5.
Haymart MR, Glinberg SL, Liu J, Sippel RS, Jaume JC, Chen H. Higher serum TSH in thyroid cancer patients occurs independent of age and correlates with extrathyroidal extension. Clin Endocrinol (Oxf). 2008 Dec 3. [Epub ahead of print]